{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:50:58Z","timestamp":1791870658587,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US-NIH","award":["HL63760"],"award-info":[{"award-number":["HL63760"]}]},{"name":"US-NIH","award":["HL59225"],"award-info":[{"award-number":["HL59225"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.pharmthera.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T09:24:56Z","timestamp":1291281896000},"page":"321-331","source":"Crossref","is-referenced-by-count":119,"title":["Copper and homocysteine in cardiovascular diseases"],"prefix":"10.1016","volume":"129","author":[{"given":"Y. James","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0005","first-page":"199","article-title":"Letter: ischemic heart disease, water hardness and myocardial magnesium","volume":"113","author":"Anderson","year":"1975","journal-title":"Can Med Assoc J"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0162-0134(03)00133-8","article-title":"Copper\u2013homocysteine complexes and potential physiological actions","volume":"95","author":"Apostolova","year":"2003","journal-title":"J Inorg Biochem"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.11.004_bb0015","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/jn\/135.10.2367","article-title":"Supplementing copper at the upper level of the adult dietary recommended intake induces detectable but transient changes in healthy adults","volume":"135","author":"Araya","year":"2005","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1568016054368197","article-title":"Influence of impaired liver methionine metabolism on the development of vascular disease and inflammation","volume":"3","author":"Avila","year":"2005","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0025","first-page":"59392","article-title":"Protein homocysteinylation: a new mechanism of atherogenesis?","author":"Beltowski","year":"2005","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"11","key":"10.1016\/j.pharmthera.2010.11.004_bb0030","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1006\/jmcc.1997.0535","article-title":"Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury","volume":"29","author":"Berenshtein","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0035","first-page":"3668","article-title":"Mitochondrial respiration in heart, liver, and kidney of copper-deficiency rats","author":"Bode","year":"1992","journal-title":"J Nutr Biochem"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ahj.2005.04.025","article-title":"Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials","volume":"151","year":"2006","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0045","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1177\/153537020623100918","article-title":"In vitro interaction between homocysteine and copper ions: potential redox implications","volume":"231","author":"Carrasco-Pozo","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0050","first-page":"4105","article-title":"Copper, manganese, zinc, and cadmium in tissues from New Zealanders","author":"Casey","year":"1982","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/156801605774322319","article-title":"Homocysteine-lowering treatment in coronary heart disease","volume":"3","author":"Cesari","year":"2005","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.numecd.2004.04.002","article-title":"Is homocysteine important as risk factor for coronary heart disease?","volume":"15","author":"Cesari","year":"2005","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4\u20136","key":"10.1016\/j.pharmthera.2010.11.004_bb0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vph.2008.06.008","article-title":"Endothelial nitric oxide (NO) and its pathophysiologic regulation","volume":"49","author":"Chatterjee","year":"2008","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/157340209788166940","article-title":"Hyperhomocysteinemia and endothelial dysfunction","volume":"5","author":"Cheng","year":"2009","journal-title":"Curr Hypertens Rev"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0075","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1073\/pnas.90.3.1102","article-title":"Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury","volume":"90","author":"Chevion","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0002-8703(78)90503-3","article-title":"Differences in metal content of the heart muscle in death from ischemic heart disease","volume":"95","author":"Chipperfield","year":"1978","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2005-872407","article-title":"Homocysteine-lowering trials for prevention of heart disease and stroke","volume":"5","author":"Clarke","year":"2005","journal-title":"Semin Vasc Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2002-36768","article-title":"Homocysteine and coronary heart disease","volume":"2","author":"Clarke","year":"2002","journal-title":"Semin Vasc Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.11.004_bb0095","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2337\/diabetes.54.5.1468","volume":"54","author":"Cooper","year":"2005","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0100","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2337\/diabetes.53.9.2501","article-title":"Regeneration of the heart in diabetes by selective copper chelation","volume":"53","author":"Cooper","year":"2004","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2010.11.004_bb0105","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/1358836X0501000105","article-title":"ADMA and hyperhomocysteinemia","volume":"10","author":"Dayal","year":"2005","journal-title":"Vasc Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00424-010-0797-1","article-title":"Hormonal modulation of endothelial NO production","volume":"459","author":"Duckles","year":"2010","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(83)90080-3","article-title":"Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency","volume":"127","author":"Dudman","year":"1983","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.11.004_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/15353702-0322807-06","article-title":"Congestive heart failure in copper-deficient mice","volume":"228","author":"Elsherif","year":"2003","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jn\/134.4.855","article-title":"Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice","volume":"134","author":"Elsherif","year":"2004","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.bjp.0702374","article-title":"Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta","volume":"126","author":"Emsley","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0014-5793(02)03571-8","article-title":"Homocysteine promotes the LDL oxidase activity of ceruloplasmin","volume":"531","author":"Exner","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0140","first-page":"25177","article-title":"Vasoreactivity in an adult rat model of marginal copper deficiency","author":"Falcone","year":"2005","journal-title":"Nutr Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mol.108.051516","article-title":"Copper regulation of hypoxia-inducible factor-1 activity","volume":"75","author":"Feng","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0150","first-page":"53","article-title":"Hyperhomocysteinemia in renal diseases","volume":"2","author":"Ferechide","year":"2009","journal-title":"J Med Life"},{"issue":"12","key":"10.1016\/j.pharmthera.2010.11.004_bb0155","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/oxfordjournals.aje.a010168","article-title":"Serum copper concentration and coronary heart disease among US adults","volume":"151","author":"Ford","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/B:BOLI.0000016614.47380.2f","article-title":"Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?","volume":"27","author":"Freisinger","year":"2004","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2010.11.004_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0300-483X(03)00159-8","article-title":"Copper toxicity, oxidative stress, and antioxidant nutrients","volume":"189","author":"Gaetke","year":"2003","journal-title":"Toxicology"},{"issue":"12","key":"10.1016\/j.pharmthera.2010.11.004_bb0170","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.fct.2004.07.020","article-title":"Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction","volume":"42","author":"Galhardi","year":"2004","journal-title":"Food Chem Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2010.11.004_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11010-009-0318-8","article-title":"New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications","volume":"334","author":"Garthwaite","year":"2010","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1203\/00006450-197005000-00003","article-title":"Cardiac hypertrophy in rats with iron and copper deficiency: quantitative contribution of mitochondrial enlargement","volume":"4","author":"Goodman","year":"1970","journal-title":"Pediatr Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.11.004_bb0185","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0022-2275(20)39141-0","article-title":"Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein","volume":"37","author":"Halvorsen","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0190","first-page":"22439","article-title":"Ceruloplasmin metabolism and function","author":"Hellman","year":"2002","journal-title":"Annu Rev Nutr"},{"issue":"7","key":"10.1016\/j.pharmthera.2010.11.004_bb0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/iub.50","article-title":"Mitochondrial copper metabolism and delivery to cytochrome c oxidase","volume":"60","author":"Horn","year":"2008","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A","article-title":"Copper stimulates proliferation of human endothelial cells under culture","volume":"69","author":"Hu","year":"1998","journal-title":"J Cell Biochem"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2010.11.004_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.05.021","article-title":"Antibodies to oxidized LDL in atherosclerosis development\u2014clinical and animal studies","volume":"348","author":"Hulthe","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02990200","article-title":"Serum zinc and copper in myocardial infarction with particular reference to prognosis","volume":"31","author":"Jain","year":"1991","journal-title":"Biol Trace Elem Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.11.004_bb0215","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/hmg\/9.5.795","article-title":"Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency","volume":"9","author":"Jaksch","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"15","key":"10.1016\/j.pharmthera.2010.11.004_bb0220","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fasebj.13.15.2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski","year":"1999","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0225","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharmthera.2010.11.004_bb0230","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1515\/CCLM.2003.224","article-title":"Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans","volume":"41","author":"Jakubowski","year":"2003","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.87.1.45","article-title":"Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis","volume":"87","author":"Jakubowski","year":"2000","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.11.004_bb0240","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0003-4975(02)03807-9","article-title":"Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting","volume":"74","author":"Jeremy","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0245","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20061943","article-title":"Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice","volume":"204","author":"Jiang","year":"2007","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3181\/00379727-221-44397","article-title":"Copper deprivation potentiates oxidative stress in HL-60 cell mitochondria","volume":"221","author":"Johnson","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0255","first-page":"166","article-title":"Non-dialyzable manganese and copper levels in serum of patients with various diseases","volume":"8","author":"Kanabrocki","year":"1967","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0260","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1525-1373.2000.22340.x","article-title":"Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart","volume":"223","author":"Kang","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.11.004_bb0265","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/labinvest.3780078","article-title":"Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide","volume":"80","author":"Kang","year":"2000","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0270","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1464-410x.1999.00253.x","article-title":"The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: new risk factors for angiopathic erectile dysfunction?","volume":"84","author":"Khan","year":"1999","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0275","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nchembio.72","article-title":"Mechanisms for copper acquisition, distribution and regulation","volume":"4","author":"Kim","year":"2008","journal-title":"Nat Chem Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0280","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1042\/bst0181186","article-title":"Studies in copper status and atherosclerosis","volume":"18","author":"Kinsman","year":"1990","journal-title":"Biochem Soc Trans"},{"issue":"9 Suppl","key":"10.1016\/j.pharmthera.2010.11.004_bb0285","doi-asserted-by":"crossref","first-page":"2419S","DOI":"10.1093\/jn\/126.suppl_9.2419S","article-title":"Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations about copper","volume":"126","author":"Klevay","year":"1996","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0290","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/oxfordjournals.aje.a114975","article-title":"Serum copper and zinc and the risk of death from cancer and cardiovascular disease","volume":"128","author":"Kok","year":"1988","journal-title":"Am J Epidemiol"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2010.11.004_bb0295","first-page":"H855","article-title":"Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency","volume":"245","author":"Kopp","year":"1983","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0300","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1464-410X.2006.06212.x","article-title":"Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit","volume":"98","author":"Koupparis","year":"2006","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.0959-9673.2005.00432.x","article-title":"Dietary copper supplements modulate aortic superoxide dismutase, nitric oxide and atherosclerosis","volume":"86","author":"Lamb","year":"2005","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0310","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1358863X10371685","article-title":"Molecular mechanisms of endothelial differentiation","volume":"15","author":"Le Bras","year":"2010","journal-title":"Vasc Med"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.11.004_bb0315","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","article-title":"Mechanisms of homocysteine-induced atherothrombosis","volume":"3","author":"Lentz","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI118771","article-title":"Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia","volume":"98","author":"Lentz","year":"1996","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0325","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/jn\/135.9.2130","article-title":"Marginal dietary copper restriction induces cardiomyopathy in rats","volume":"135","author":"Li","year":"2005","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0330","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.nbd.2006.06.010","article-title":"Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells","volume":"23","author":"Linnebank","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2010.07.071","article-title":"Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes","volume":"1355","author":"Loureiro","year":"2010","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0340","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/10408360801991055","article-title":"Diagnosis of Wilson's disease: a comprehensive review","volume":"45","author":"Mak","year":"2008","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0345","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.99.1.178","article-title":"Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association","volume":"99","author":"Malinow","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0350","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","article-title":"Mechanisms and models in heart failure: a combinatorial approach","volume":"100","author":"Mann","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/clinchem\/46.3.385","article-title":"Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease","volume":"46","author":"Mansoor","year":"2000","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.pharmthera.2010.11.004_bb0360","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1182\/blood-2004-10-3980","article-title":"Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation","volume":"105","author":"Martin","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0365","first-page":"203","article-title":"Comparison of inorganic elements from autopsy tissue of young and elderly subjects","volume":"5","author":"Martin","year":"1991","journal-title":"J Trace Elem Electrolytes Health Dis"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0370","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0375","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jn\/121.6.815","article-title":"Myofibrillar, mitochondrial and valvular morphological alterations in cardiac hypertrophy among copper-deficient rats","volume":"121","author":"Medeiros","year":"1991","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0380","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3181\/00379727-203-43599","article-title":"A unified perspective on copper deficiency and cardiomyopathy","volume":"203","author":"Medeiros","year":"1993","journal-title":"Proc Soc Exp Biol Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0385","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3181\/00379727-215-44141","article-title":"Newer findings on a unified perspective of copper restriction and cardiomyopathy","volume":"215","author":"Medeiros","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0390","first-page":"339","article-title":"Serum copper, ceruloplasmin & iron in ischaemic heart disease","volume":"30","author":"Misra","year":"1978","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbadis.2003.10.005","article-title":"Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation","volume":"1688","author":"Nakano","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0400","first-page":"7,340","article-title":"Trace element levels in serum and urine of subjects died of coronary heart disease","volume":"59 Suppl","author":"Niskanen","year":"1986","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0405","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/15513","article-title":"Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene","volume":"23","author":"Papadopoulou","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0955-2863(90)90080-5","article-title":"Biochemical changes in copper deficiency","volume":"1","author":"Prohaska","year":"1990","journal-title":"J Nutr Biochem"},{"issue":"11","key":"10.1016\/j.pharmthera.2010.11.004_bb0415","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/jn\/112.11.2142","article-title":"Mechanical properties of the copper-deficient rat heart","volume":"112","author":"Prohaska","year":"1982","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0420","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.284.5415.805","article-title":"Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase","volume":"284","author":"Rae","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0425","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2006.11.038","article-title":"Promotion of atherogenesis by copper or iron\u2014which is more likely?","volume":"353","author":"Rajendran","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0430","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ajcn\/42.2.242","article-title":"Indices of copper status in humans consuming a typical American diet containing either fructose or starch","volume":"42","author":"Reiser","year":"1985","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0435","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/oxfordjournals.aje.a116573","article-title":"Serum ceruloplasmin level and the risk of myocardial infarction and stroke","volume":"136","author":"Reunanen","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.11.004_bb0440","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1139\/y00-054","article-title":"Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration","volume":"78","author":"Saari","year":"2000","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0445","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/oxfordjournals.aje.a116080","article-title":"Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland","volume":"134","author":"Salonen","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"Pt 2","key":"10.1016\/j.pharmthera.2010.11.004_bb0450","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/0264-6021:3630321","article-title":"Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations","volume":"363","author":"Salviati","year":"2002","journal-title":"Biochem J"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0455","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0021-9681(66)90033-6","article-title":"Essential trace metals in man: copper","volume":"19","author":"Schroeder","year":"1966","journal-title":"J Chron Dis"},{"issue":"6 Suppl","key":"10.1016\/j.pharmthera.2010.11.004_bb0460","doi-asserted-by":"crossref","first-page":"1726S","DOI":"10.1093\/jn\/136.6.1726S","article-title":"The many facets of hyperhomocysteinemia: studies from the Framingham cohorts","volume":"136","author":"Selhub","year":"2006","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0465","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.athoracsur.2007.03.087","article-title":"Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein","volume":"84","author":"Shukla","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2010.11.004_bb0470","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2005.12.003","article-title":"Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit","volume":"531","author":"Shukla","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0475","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/07315724.1997.10718650","article-title":"Epidemiologic study of trace elements and magnesium on risk of coronary artery disease in rural and urban Indian populations","volume":"16","author":"Singh","year":"1997","journal-title":"J Am Coll Nutr"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.11.004_bb0480","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/000331978503600805","article-title":"Serum copper in myocardial infarction\u2014diagnostic and prognostic significance","volume":"36","author":"Singh","year":"1985","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0485","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)62949-5","article-title":"Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury","volume":"167","author":"Song","year":"2005","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0490","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0162-0134(01)00376-2","article-title":"Roles of metallothionein in copper homeostasis: responses to Cu-deficient diets in mice","volume":"88","author":"Suzuki","year":"2002","journal-title":"J Inorg Biochem"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0495","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.nut.2004.05.011","article-title":"Effect of long-term, high-copper intake on the concentrations of plasma homocysteine and B vitamins in young men","volume":"20","author":"Tamura","year":"2004","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0500","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0753-3322(03)00012-X","article-title":"Trace elements in human physiology and pathology. Copper","volume":"57","author":"Tapiero","year":"2003","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0505","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0014-4800(74)90103-8","article-title":"Lipid and trace metal content in coronary arteries of Nigerian Africans","volume":"21","author":"Taylor","year":"1974","journal-title":"Exp Mol Pathol"},{"issue":"12","key":"10.1016\/j.pharmthera.2010.11.004_bb0510","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.freeradbiomed.2004.03.019","article-title":"Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin","volume":"36","author":"Topal","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0515","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-8223(01)00078-5","article-title":"Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc","volume":"101","author":"Trumbo","year":"2001","journal-title":"J Am Diet Assoc"},{"issue":"3","key":"10.1016\/j.pharmthera.2010.11.004_bb0520","first-page":"129","article-title":"Homocysteine altered ROS generation and NO accumulation in endothelial cells","volume":"46","author":"Tsen","year":"2003","journal-title":"Chin J Physiol"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0525","first-page":"499","article-title":"Antiatherogenic effect of high density lipoprotein","volume":"56","author":"Turczyn","year":"2002","journal-title":"Postepy Hig Med Dosw"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0530","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI118763","article-title":"The effect of a subnormal vitamin B-6 status on homocysteine metabolism","volume":"98","author":"Ubbink","year":"1996","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0535","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.STR.0000128412.59768.6e","article-title":"Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis","volume":"35","author":"Undas","year":"2004","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.pharmthera.2010.11.004_bb0540","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1651-2227.2004.tb02929.x","article-title":"Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene","volume":"93","author":"Vesela","year":"2004","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.pharmthera.2010.11.004_bb0545","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ajcn\/35.2.258","article-title":"A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency","volume":"35","author":"Viestenz","year":"1982","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.pharmthera.2010.11.004_bb0550","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1210\/jc.2004-0419","article-title":"Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: an in vitro study","volume":"89","author":"Vignini","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0555","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.0954-6820.1965.tb04329.x","article-title":"Trace elements in human myocardial infarction determined by neutron activation analysis","volume":"178","author":"Wester","year":"1965","journal-title":"Acta Med Scand"},{"issue":"5","key":"10.1016\/j.pharmthera.2010.11.004_bb0560","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1046\/j.1471-4159.2001.00178.x","article-title":"Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways","volume":"76","author":"White","year":"2001","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.pharmthera.2010.11.004_bb0565","first-page":"375","article-title":"Tissue copper concentrations of patients with Menke's kinky hair disease","volume":"135","author":"Williams","year":"1981","journal-title":"Am J Dis Child"},{"issue":"6","key":"10.1016\/j.pharmthera.2010.11.004_bb0570","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9343(92)90783-8","article-title":"Wilson's disease: current status","volume":"92","author":"Yarze","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.pharmthera.2010.11.004_bb0575","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02795618","article-title":"Cardiac copper, magnesium, and zinc in recent and old myocardial infarction","volume":"10","author":"Zama","year":"1986","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2010.11.004_bb0580","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jnutbio.2008.06.007","article-title":"Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes","volume":"20","author":"Zhou","year":"2009","journal-title":"J Nutr Biochem"},{"issue":"1","key":"10.1016\/j.pharmthera.2010.11.004_bb0585","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2009.01.035","article-title":"S-homocysteinylated LDL apolipoprotein B adversely affects human endothelial cells in vitro","volume":"206","author":"Zinellu","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2010.11.004_bb0590","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/ars.2005.7.547","article-title":"Homocysteine and redox signaling","volume":"7","author":"Zou","year":"2005","journal-title":"Antioxid Redox Signal"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725810002196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725810002196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:01:46Z","timestamp":1740740506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725810002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0163725810002196"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2010.11.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}